Depressive reactions to lung cancer are common and often followed by a poor outcome

European Respiratory Journal

Volumn 11, Issue 1, 1998, Pages 173-178

  Buccheri, G ^a  

^a S CROCE E CARLE HOSPITAL   (Italy)

Author keywords

Lung cancer; Mental depression; Prognosis

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CONTROLLED STUDY; DEPRESSION; FEMALE; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; QUESTIONNAIRE; RATING SCALE; SELF EVALUATION; TREATMENT OUTCOME;

AGED; DEPRESSION; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; PSYCHIATRIC STATUS RATING SCALES; QUESTIONNAIRES; SURVIVAL ANALYSIS;

EID: 0031892681     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.98.11010173     Document Type: Article

References (32)

1. Minna JD, Higgins GA, Glatstein EJ. Cancer of the lung. In: De Vita V Jr, Hellman S, Rosemberg SA, eds. Cancer. Principles and Practice of Oncology. Philadelphia, J.B. Lippincott Co., 1985: pp. 507-597.
2. Kaasa S, Mastekaasa A, Lund E. Prognostic factors for patients with inoperable non-small cell lung cancer, limited disease. The importance of patients' subjective experience of disease and psychosocial well-being. Radiother Oncol 1989; 15: 235-242.
3. Buccheri G, Vola F, Ferrigno D. Aspects of quality of life in patients with lung cancer: a three observer evaluation study. Int J Oncol 1993; 2: 537-544.
4. Ganz PA, Lee JJ, Siau J. Quality of life assessment. An independent prognostic variable for survival in lung cancer. Cancer 1991; 67: 3131-3135.
5. Ruckdeschel JC, Piantadosi S, the Lung Cancer Study Group. Quality of life assessment in lung surgery for bronchogenic carcinoma. J Theor Surgery 1991; 6: 201-205 (Abstract).
6. Buccheri G: The patient's perception of his own quality of life affects the prognosis of lung cancer. Supp Care Oncol 1995; 16: 11-13.
7. Bergman B, Aaronson NK, Ahmedzai S, Kaasa S, Sullivan M. The EORTC QLQ-LC13: a modular supplement to the EORTC core quality of life questionnaire (QLQ-C30) for use in lung cancer clinical trials. Eur J Cancer [A] 1994; 30A: 635-642.
8. Hollen PJ, Gralla RJ, Kris MG, Potanovich LM. Quality of life assessment in individuals with lung cancer: testing the Lung Cancer Symptom Scale (LCSS). Eur J Cancer [A] 1993; 29A Suppl. 1: S51-S58.
9. Tamburini M, Rosso S, Gamba A, Mencaglia E, De Conno F, Ventafridda V. A therapy impact questionnaire for quality-of-life assessment in advanced cancer research. Ann Oncol 1992; 3: 565-570.
10. Hopwood P. Progress, problems and priorities in quality of life research. Eur J Cancer [A] 1992; 28A: 1748-1752.
11. Zubrod CG, Scheiderman MA, Frei E, et al. Appraisal of methods for the study of chemotherapy in man: comparative therapeutic trial of nitrogen mustard and triethylene thiophosphoramide. J Chron Dis 1960; 11: 7-33.
12. Buccheri G, Biggi A, Ferrigno D, et al. Anti-CEA immunoscintigraphy and computed tomographic scanning in the preoperative evaluation of mediastinal lymph nodes in lung cancer. Thorax 1996; 51: 359-363.
13. World Health Organization. International Histological Classification of Tumours. Berlin, Springer-Verlag, 1991.
14. UICC. TNM Classification of Malignant tumours. Berlin, Springer-Verlag, 1987; p. 69.
15. Zung WWK. A self-rating depression scale. Arch Gen Psychiatry 1965; 12: 63-70.
16. Buccheri G, Ferrigno D, Tamburini M, Brunelli C. The patient's perception of his own quality of life might have an adjunctive prognostic significance in lung cancer. Lung Cancer 1995; 12: 45-58.
17. Zung WWK. A cross-cultural survey of symptoms in depression. Am J Psychiatry 1969; 126: 154-159.
18. Zung WWK. From art to science. Arch Gen Psychiatry 1973; 29: 328-337.
19. Siegel S. Nonparametric statistics for the Behavioural Sciences, New York, MacGraw Hill, 1956.
20. Kaplan EL, Meier F. Non-parametric estimation from incomplete observations. J Am Stat Assoc 1958; 58: 457-481.
21. Lee ET, Desu MM. A computer program for comparing K samples with right-censored data. Computer Progr Biomed 1972; 2: 315-321.
22. Gehan EA. A generalized Wilcoxon test for comparing arbitrarily singly-censored samples. Biometrika 1965; 52: 203-223.
23. Cox DR. Regression models and life tables. J R Stat Soc 1972; 34: 187-220.
24. Buccheri G, Barberis P, Delfino MS. Diagnostic, morphologic, and histopathologic correlates in bronchogenic carcinoma. A review of 1045 bronchoscopic examinations. Chest 1991; 99: 809-814.
25. Buccheri G, Ferrigno D. Prognostic value of the tissue polyptide antigen in lung cancer. Chest 1992; 101: 1287-1292.
26. Stahel RA, Ginsberg R, Havemann K, et al. Staging and prognostic factors in small cell lung cancer: a consensus report. Lung Cancer 1989; 5: 119-126.
27. Feld R, Arriagada R, Ball DL, Mattson K, Sorensen JB. Prognostic factors in non-small cell lung cancer: a consensus report. Lung Cancer 1991; 7: 3-5.
28. Buccheri G, Ferrigno D. Prognostic factors in lung cancer: tables and comments. Eur Respir J 1994; 7: 1350-1364.
29. Kibbellaar RE, Moolenaar KEC, Michalides RJAM, et al. Neural cell adhesion molecule expression, neuroendocrine differentiation and prognosis in lung carcinoma. Eur J Cancer 1991; 27: 431-435.
30. Van der Gaast A, Van Putten WL, Oosterom R, Cozijnsen M, Hoekstra R, Splinter TAW. Prognostic value of serum thymidine kinase, tissue polypetide antigen and neuron specific enolase in patients with small cell lung cancer. Br J Cancer 1991; 64: 369-372.
31. Buccheri G, Ferrigno D, Vola F. Carcinoembryonic antigen (CEA), tissue polyptide antigen (TPA), and other prognostic indicators in the squamous cell carcinoma of the lung. Lung Cancer 1993; 10: 21-33.
32. Pedersen AC, Bach FW, Nissen M, Bach F. Creatine kinase BB and beta-2-microglohulin as markers of CNS metastasis in patients with small-cell lung cancer. J Clin Oncol 1985; 3: 1364-1372.